Le Lézard
Classified in: Health
Subjects: CHI, LEG, AVO

Statement from Madeline Bell, President and CEO of the Children's Hospital of Philadelphia (CHOP), On 6/20 Executive Order that Temporarily Ends Family Separation:


PHILADELPHIA, June 20, 2018 /PRNewswire-USNewswire/ -- "Today's executive order appears to have suspended parent and child separation at our southern borders, and it is important that families are reunited quickly.  This situation continues to result in unnecessary trauma being inflicted on children. As CEO of CHOP ? the nation's first children's hospital ? I interact daily with experts in their field who have long treated and studied the impact of family separation on refugee and immigrant children. The science is indisputable ? family preservation is a critical component to ensuring childhood resilience.

Madeline Bell, President and CEO of the Children's Hospital of Philadelphia (CHOP)

The truth is that sudden, unexpected or traumatic loss or separation from parents can have devastating, long-term effects on the physical and psychological health of children. Prolonged placement in detention centers or institutional environments only compounds the lasting impact. From post-traumatic stress disorder, to toxic stress, to permanent physiological changes that can alter brain development, immune health and a host of other vital functions ? the science is quite clear.

At a time when innocent children ? many of whom have already fled from dangerous living conditions, often marked by violence and instability ? would benefit from the presence of safe, loving and consistent caretakers, forcibly separating families only stands to do harm to their physical and mental health beyond measure.

As health care providers, it is our responsibility to advocate for those who do not have a voice. Quickly reuniting these families will help ensure these children can lead healthy and fulfilling lives."

SOURCE Children's Hospital of Philadelphia


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: